Your browser doesn't support javascript.
loading
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.
Cheng, Zhao; Mirza, Hasan; Ennis, Darren P; Smith, Philip; Morrill Gavarró, Lena; Sokota, Chishimba; Giannone, Gaia; Goranova, Theodora; Bradley, Thomas; Piskorz, Anna; Lockley, Michelle; Kaur, Baljeet; Singh, Naveena; Tookman, Laura A; Krell, Jonathan; McDermott, Jacqueline; Macintyre, Geoffrey; Markowetz, Florian; Brenton, James D; McNeish, Iain A.
Afiliación
  • Cheng Z; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • Mirza H; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • Ennis DP; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • Smith P; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Morrill Gavarró L; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Sokota C; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Giannone G; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • Goranova T; Department of Oncology, University of Turin, Turin, Italy.
  • Bradley T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Piskorz A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Lockley M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Singh N; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Tookman LA; Department of Pathology, Barts Healthcare NHS Trust, London, United Kingdom.
  • Krell J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • McDermott J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
  • Macintyre G; Department of Pathology, University College London Hospital NHS Trust, London, United Kingdom.
  • Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • McNeish IA; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Clin Cancer Res ; 28(13): 2911-2922, 2022 07 01.
Article en En | MEDLINE | ID: mdl-35398881
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido